Picture of IDEX logo

IEX — IDEX News Story

0.000.00%
us flag iconLast trade - 00:00
IndustrialsConservativeLarge CapHigh Flyer

IDEX Q2 sales rise 7% to $865 mln, beat expectations

Overview

IDEX Q2 sales rise 7% yr/yr to $865 mln, beating analyst expectations

Adjusted EPS for Q2 exceeds analyst expectations, per LSEG data

Outlook

IDEX revises full-year EPS to $6.30-$6.44 GAAP, $7.85-$7.95 adjusted

Company expects Q3 2025 GAAP EPS of $1.54-$1.61

IDEX sees Q3 organic sales growth of 2%-3%

Company anticipates full-year organic sales growth of 1%

Result Drivers

MOTT ACQUISITION - Sales increase driven by Mott acquisition and positive pricing strategies

VOLUME DELEVERAGE - Gross margin affected by unfavorable mix and volume deleverage, partially offset by productivity improvements

INTEREST EXPENSE - Higher interest expense due to debt from Mott acquisition impacted EPS

Key Details

MetricBeat/MissActualConsensus Estimate
Q2 SalesBeat$865.40 mln$858.70 mln (9 Analysts)
Q2 Adjusted EPSBeat$2.07$1.99 (9 Analysts)
Q2 EPS$1.74
Q2 Adjusted Net IncomeBeat$156.50 mln$151 mln (6 Analysts)
Q2 Adjusted EBITDABeat$237.20 mln$209.90 mln (2 Analysts)
Q2 Adjusted Gross Margin45.3%
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell" The average consensus recommendation for the industrial machinery & equipment peer group is "buy" Wall Street's median 12-month price target for IDEX Corp is $215.50, about 14.1% above its July 29 closing price of $185.18 The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 21 three months ago Press Release: ID:nBw2qj4d7a (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on IDEX

See all news